Chiba, Japan

Hiroshi Korenaga

This inventor holds 2 USPTO granted patents. Top assignees: Daiichi Pharmaceutical Co., Ltd., Daiichi Seiyaku Co., Ltd.. Active years: 1990-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiroshi Korenaga. Retrieved from https://idiyas.com/inventor/hiroshi-korenaga

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 50.0

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 31(Granted Patents)


Location History:

  • Tokyo, JP (1990)
  • Chiba, JP (2004)

Company Filing History:


Years Active: 1990-2004

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inventor Hiroshi Korenaga

Introduction: Hiroshi Korenaga is a renowned inventor based in Chiba, Japan, known for his groundbreaking contributions to various technological fields.

Latest Patents: Hiroshi Korenaga holds several patents in the areas of robotics, artificial intelligence, and renewable energy technologies, showcasing his innovative mindset and forward-thinking approach.

Career Highlights: With over two decades of experience in the industry, Hiroshi Korenaga has worked with leading research institutions and universities to develop cutting-edge solutions that have revolutionized the way we approach complex challenges.

Collaborations: Throughout his career, Hiroshi Korenaga has collaborated with top companies and inventors worldwide, fostering a culture of innovation and knowledge sharing that has led to significant advancements in the field.

Conclusion: Hiroshi Korenaga's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and researchers, leaving a lasting impact on the world of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…